Download PDF
Thromb Haemost 2000; 84(04): 591-594
DOI: 10.1055/s-0037-1614072
Review Article
Schattauer GmbH

Factor XIII Deficiency Causing Mutation, Ser295Arg, in Exon 7 of the Factor XIIIA Gene

Rashida Anwar
1   From the Molecular Medicine Unit, University of Leeds, Clinical Sciences Building, St James’s University Hospital, Leeds, UK
,
Louise Gallivan
1   From the Molecular Medicine Unit, University of Leeds, Clinical Sciences Building, St James’s University Hospital, Leeds, UK
,
Krzysztof J. A. Miloszewski
1   From the Molecular Medicine Unit, University of Leeds, Clinical Sciences Building, St James’s University Hospital, Leeds, UK
,
Alexander F. Markham
1   From the Molecular Medicine Unit, University of Leeds, Clinical Sciences Building, St James’s University Hospital, Leeds, UK
› Author AffiliationsWe would like to thank Professor S.E.V. Phillips and Dr C. H. Trinh for helpful discussions on the structural implications of the FXIII Arg295 mutant and assistance with preparation of Fig. 3. Research in our laboratories is supported by the NHS Executive, the Wellcome Trust, Yorkshire Cancer Research and The Royal Society.
Further Information

Publication History

Received 11 August 1999

Accepted after resubmission 21 March 2000

Publication Date:
11 December 2017 (online)

    Permissions and Reprints

Summary

Inherited factor XIII (FXIII) deficiency is an autosomal recessive disorder which results in a serious bleeding diathesis, problems with wound healing and a very high risk of recurrent miscarriage in deficient females. We have analysed the molecular basis of factor XIII deficiency in two patients and their parents, who originate from the North of Pakistan. Four sequence changes were identified: an AGC→AGG (Ser→Arg) FXIII deficiency-causing mutation in codon 295; G→A at position -246 upstream of exon 1; T→C and C→T at positions -23 and -24, respectively, in intron 9. Using molecular modelling we predict that the Ser295Arg mutation would prevent the FXIIIA molecule from folding correctly and thus result in an unstable FXIIIA mutant polypeptide. The sequence changes −246G→A, −23T→C and −24C→T are normal polymorphisms. RT-PCR analysis demonstrates that the intronic sequence changes do not appear to affect the accuracy of FXIIIA RNA processing.

Key words

Factor XIII - transglutaminase - deficiency - missense mutation
 

  • References

  • 1 Aeshlimann D, Paulsson M. Transglutaminases: Protein cross-linking enzymes in tissues and body fluids. Thromb Haemost 1994; 71: 402-15.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 2 Lorand L, Losowsky MS, Miloszewski KJA. Human factor XIII fibrin stabilizing factor. Prog Thromb Haemost 1980; 05: 245-90.
    PubMedGoogle Scholar
  • 3 Schwartz ML, Pizzo SV, Hill RL, McKee PA. Human factor XIII from plasma and platelets. Molecular weights, subunit structures, proteolytic activation and cross-linking of fibrinogen and fibrin. J Biol Chem 1973; 248: 1359-407.
    PubMedGoogle Scholar
  • 4 Board PG, Losowsky MS, Miloszewski KJA. Factor XIII: inherited and acquired deficiency. Blood Reviews 1993; 07: 229-40.
    CrossrefPubMedGoogle Scholar
  • 5 Duckert F, Jung E, Shmerling DH. A hitherto undescribed congenital haemorrhagic diathesis probably due to fibrin stabilising factor deficiency. Thromb, Diathesis Haemorrh 1960; 05: 179-86.
    PubMedGoogle Scholar
  • 6 Miloszewski KJA, Losowsky MS. Fibrin stabilisation and factor XIII deficiency. In Fibrinogen, Fibrin Stabilisation and Fibrinolysis. Francis L. Ellis Horwood; 1988: 175-202.
    Google Scholar
  • 7 Anwar R, Miloszewski KJA. Factor XIII deficiency. Brit J Haem 1999; 107: 468-84.
    CrossrefPubMedGoogle Scholar
  • 8 Barry ELR, Mosher DF. Factor XIIIa-mediated cross-linking of fibronectin in fibroblast cell-layers: cross-linking of cellular and plasma fibronectin and of amino-terminal fibronectin fragments. J Biol Chem 1989; 264: 4179-85.
    PubMedGoogle Scholar
  • 9 Sane DC, Moser TL, Pippen AMM, Parker CJ, Achyuthan KE, Greenberg CS. Vitronectin is a substrate for transglutaminases. Biochem Biophys Res Commun 1988; 157: 115-20.
    CrossrefPubMedGoogle Scholar
  • 10 Paye M, Nusgens B, Lapiere CM. Factor XIII of blood coagulation decreases the susceptibility of collagen precursers to proteolysis. Biochim Biophys Acta 1991; 1073: 437-41.
    CrossrefPubMedGoogle Scholar
  • 11 Borth W, Chang V, Bishop P, Harpel PC. Lipoprotein(a) is a substrate for factor XIIIa and tissue transglutaminase. J Biol Chem 1991; 266: 18149-53.
    PubMedGoogle Scholar
  • 12 McDonagh J. Biochemistry of fibrin stabilising factor (FXIII). In Factor XIII. 2nd International Conference. McDonagh J, Seitz R, Egbring R. Schattauer; Stuttgart: 1993: 2-8.
    Google Scholar
  • 13 Wisen O, Gardlund B. Hemostasis in Crohn’s disease: Low FXIII levels in active disease. Scand J Gastroent 1988; 23: 961-6.
    CrossrefPubMedGoogle Scholar
  • 14 Suzuki R, Toda H, Takamura Y. Dynamics of blood coagulation factor XIII in ulcerative colitis and preliminary study of the factor XIII concentrate. Blut 1989; 59: 162-4.
    CrossrefPubMedGoogle Scholar
  • 15 van Wersch JWJ, Peters C, Ubachs JMH. Coagulation factor XIII in plasma of patients with benign and malignant gynaecological tumours. Eur J Clin Chem Clin Biochem 1994; 32: 681-4.
    PubMedGoogle Scholar
  • 16 Kohler UP, Grant PJ. The role of factor XIIIVal34Leu in cardiovascular disease. Quart J Med 1999; 92: 67-72.
    CrossrefPubMedGoogle Scholar
  • 17 Ichinose A, Davie EW. Characterisation of the gene for the a subunit of factor XIII (plasma transglutaminase), a blood coagulation factor. Proc Natl Acad Sci USA 1988; 85: 5829-33.
    CrossrefPubMedGoogle Scholar
  • 18 Anwar R, Stewart AD, Miloszewski KJA, Losowsky MS, Markham AF. Molecular basis of inherited factor XIII deficiency: identification of multiple mutations provides insights into protein function. Br J Haem 1995; 91: 728-35.
    CrossrefPubMedGoogle Scholar
  • 19 Newton CR, Heptinstall LE, Summers C, Super M, Schwarz M, Anwar R, Graham A, Smith JC, Markham AF. Amplification refractory mutation system for prenatal diagnosis and carrier assessment in cystic fibrosis. Lancet 1989ii; 1481-3.
    PubMedGoogle Scholar
  • 20 Anwar R, Gallivan L, Edmonds SD, Markham AF. Genotype/phenotype correlations for coagulation factor XIII: specific normal polymorphisms are associated with high or low factor XIII specific activity. Blood 1999; 93: 897-905.
    PubMedGoogle Scholar
  • 21 Yee VC, Pedersen LC, Trong IL, Bishop PD, Stenkamp RE, Teller DC. Three-dimensional structure of a transglutaminase: human blood coagulation factor XIII. Proc Natl Acad Sci USA 1994; 91: 7296-300.
    CrossrefPubMedGoogle Scholar
  • 22 Pedersen LC, Yee VC, Bishop PD, Trong IL, Teller DC, Stenkamp RE. Transglutaminase factor XIII uses proteinase-like catalytic triad to crosslink macromolecules. Protein Sci 1994; 03: 1131-5.
    CrossrefPubMedGoogle Scholar
  • 23 Hettasch JM, Peoples KA, Greenberg CS. Analysis of factor XIII substrate specificity using recombinant human factor XIII and tissue transglutaminase chimeras. J Biol Chem 1997; 272: 25149-56.
    CrossrefPubMedGoogle Scholar
  • 24 Altschul SF, Thomas LM, Alejandro AS, Jinghui Z, Zheng Z, Webb M, Lipman DJ. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res 1997; 25: 3389-402.
    CrossrefPubMedGoogle Scholar
  • 25 Quandt K, Frech K, Karas H, Wingender E, Werner T. MatInd and MatInspector ’ New fast and versatile tools for detection of consensus matches in nucleotide sequence data. Nucleic Acids Res 1995; 23: 4878-84.
    CrossrefPubMedGoogle Scholar
  • 26 Kida M, Souri M, Yamamoto M, Saito H, Ichinose A. Transcriptional regulation of cell type-specific expression of the TATA-less A subunit gene for human coagulation factor XIII. J Biol Chem 1999; 274: 6138-47.
    CrossrefPubMedGoogle Scholar
  • 27 Ichinose A, Tsukamoto H, Izumi T, Yamazaki T, Togashi M, Takamatsu J, Saito H, Umeyama K. Arg260-Cys mutation in severe factor XIII deficiency: conformational change of the A subunit is predicted by molecular modelling and mechanics. Brit J Haem 1998; 101: 264-72.
    CrossrefPubMedGoogle Scholar
  • 28 Halliday R, Murray V. Specificity in splicing. BioEssays 1994; 16: 771-4.
    CrossrefPubMedGoogle Scholar
  • 29 Anwar R, Miloszewski KJA, Markham AF. New splicing mutations in the human FXIIIA gene, each producing multiple mutant transcripts of varying abundance. Thromb Haemost 1998; 79: 1151-6.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 30 Anwar R, Gallivan L, Miloszewski KJA, Markham AF. Splicing and missense mutations in the human FXIIIA gene causing FXIII deficiency: effects of these mutations on FXIIIA RNA processing and protein structure. Brit J Haem 1998; 103: 425-8.
    CrossrefPubMedGoogle Scholar
  • 31 Suzuki K, Henke J, Iwata M, Henke L, Tsuji H, Fukunaga T, Ishimoto G, Szekelyi M, Ito S. Novel polymorphisms and haplotypes in the human coagulation factor XIIIA subunit gene. Hum Genet 1996; 98: 393-5.
    CrossrefPubMedGoogle Scholar
  • 32 Kraulis PJ. MOLSCRIPT: a program to produce both detailed and schematic plots of protein structures. J App Crystallography 1991; 24: 946-50.
    PubMedGoogle Scholar
  • 33 Collaborative Computational Project Number 4. The CCP4 suite: programs for protein crystallography. Acta Crystallographia D 1994; 50: 760-3.
    PubMedGoogle Scholar
  • 34 Baker EN, Hubbard RE. Hydrogen bonding in globular proteins. Prog Biophys Mol Biol 1984; 44: 97-179.
    CrossrefPubMedGoogle Scholar